A phase II, multicenter, open-label, randomized trial of pegfilgrastim for patients with alcohol-associated hepatitis

John A. Tayek, Andrew A. Stolz, Danh V. Nguyen, M. Wayne Fleischman, John A. Donovan, Joseph M. Alcorn, Daniel C-K. Chao, Aliya Asghar, Timothy R. Morgan, Divya Birudaraju, Greg Botwin, Hema Buddha, Lavanya Cherukuri, Sheena Cruz, Monique French, Rachel Gonzalez, Jessica Gozum, Rebecca Gutierrez, Sajad Hamal, Preston Head, Carol Jones, Neil Kaplowitz, Robert Lee, Lauren MacHarg, Susan Milstein, Yuxin Ouyang, Christy Rico, Cory Zarick

Open source

DOI: 10.1016/j.eclinm.2022.101689
Published: 2022-12
Container: eClinicalMedicine
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2022.101689,
  title = {A phase II, multicenter, open-label, randomized trial of pegfilgrastim for patients with alcohol-associated hepatitis},
  author = {John A. Tayek and Andrew A. Stolz and Danh V. Nguyen and M. Wayne Fleischman and John A. Donovan and Joseph M. Alcorn and Daniel C-K. Chao and Aliya Asghar and Timothy R. Morgan and Divya Birudaraju and Greg Botwin and Hema Buddha and Lavanya Cherukuri and Sheena Cruz and Monique French and Rachel Gonzalez and Jessica Gozum and Rebecca Gutierrez and Sajad Hamal and Preston Head and Carol Jones and Neil Kaplowitz and Robert Lee and Lauren MacHarg and Susan Milstein and Yuxin Ouyang and Christy Rico and Cory Zarick},
  year = {2022},
  journal = {eClinicalMedicine},
  doi = {10.1016/j.eclinm.2022.101689},
  url = {https://doi.org/10.1016/j.eclinm.2022.101689}
}

RIS

TY  - JOUR
TI  - A phase II, multicenter, open-label, randomized trial of pegfilgrastim for patients with alcohol-associated hepatitis
AU  - John A. Tayek
AU  - Andrew A. Stolz
AU  - Danh V. Nguyen
AU  - M. Wayne Fleischman
AU  - John A. Donovan
AU  - Joseph M. Alcorn
AU  - Daniel C-K. Chao
AU  - Aliya Asghar
AU  - Timothy R. Morgan
AU  - Divya Birudaraju
AU  - Greg Botwin
AU  - Hema Buddha
AU  - Lavanya Cherukuri
AU  - Sheena Cruz
AU  - Monique French
AU  - Rachel Gonzalez
AU  - Jessica Gozum
AU  - Rebecca Gutierrez
AU  - Sajad Hamal
AU  - Preston Head
AU  - Carol Jones
AU  - Neil Kaplowitz
AU  - Robert Lee
AU  - Lauren MacHarg
AU  - Susan Milstein
AU  - Yuxin Ouyang
AU  - Christy Rico
AU  - Cory Zarick
PY  - 2022
JO  - eClinicalMedicine
DO  - 10.1016/j.eclinm.2022.101689
UR  - https://doi.org/10.1016/j.eclinm.2022.101689
ER  -

APA

Tayek, J. A., Stolz, A. A., Nguyen, D. V., Fleischman, M. W., Donovan, J. A., Alcorn, J. M., Chao, D. C., Asghar, A., Morgan, T. R., Birudaraju, D., Botwin, G., Buddha, H., Cherukuri, L., Cruz, S., French, M., Gonzalez, R., Gozum, J., Gutierrez, R., Hamal, S., Head, P., Jones, C., Kaplowitz, N., Lee, R., MacHarg, L., Milstein, S., Ouyang, Y., Rico, C., & Zarick, C. (2022). A phase II, multicenter, open-label, randomized trial of pegfilgrastim for patients with alcohol-associated hepatitis. eClinicalMedicine. https://doi.org/10.1016/j.eclinm.2022.101689

Source records

crossref · retrieved 2026-09-25T22:44:36.731Z